• Home>
  • Stocks>
  • Nath Bio-Genes (India) Ltd Share Price
Nath Bio-Genes (India) Ltd share price logo

Nath Bio-Genes (India) Ltd Share Price

NSE: NATHBIOGEN

BSE: 537291

Small Cap

FMCG Sector

₹168.38

+0.61

(+0.36%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Nath Bio-Genes (India) Ltd Stock Performance

as on September 15, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹166
    ₹171.13
    downward going graph

    1.41%

    Downside

    1.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹137.55
    ₹238.69
    downward going graph

    18.31%

    Downside

    41.76%

    Upside

    downward going graph

Nath Bio-Genes (India) Ltd share price movements today

Previous Close
₹167.77
Open
₹171.13
Volume
12.85K
Upper Circuit
₹176.15
Lower Circuit
₹159.38
Day's Low - High
₹166 - ₹171.13
52 Week Low - High
₹137.55 - ₹238.69

Nath Bio-Genes (India) Ltd Historical Returns

1 Month Return
-3.55 %
3 Month Return
-17.46 %
1 Year Return
-24.73 %
3 Year Return
-7.18 %
5 Year Return
-41.68 %

Nath Bio-Genes (India) Ltd Fundamentals

as on September 15, 2025 at 4:01 pm IST

Market Cap

₹318.83 Cr

Return on Equity (ROE)

6.69

PE Ratio (TTM)

7.67

Return on capital employed (ROCE)

7.25

Industry PE ratio

59.88

Beta (LTM)

1.05

P/B Ratio

0.43

Dividend Yield

1.37

PEG Ratio

-20.2

Quarterly Earnings Growth YOY

11.78

EPS (TTM)

20.31

Sector

FMCG

Book Value

339.08

Technical Analysis

Bearish

View Technical Analysis

Nath Bio-Genes (India) Ltd Stock Valuation

as on September 15, 2025 at 4:01 pm IST

Nath Bio-Genes (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-3.78x)

January 3, 2023

Today (7.67x)

September 12, 2025

Industry (59.88x)

September 12, 2025

Highest (11.85x)

August 4, 2023

LowHigh

Today’s Price to Earnings Ratio: 7.67x

Nath Bio-Genes (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nath Bio-Genes (India) Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Nath Bio-Genes (India) Ltd image
Nath Bio-Genes (India) Ltd
NA318.83-8.34%0.5838364
Vadilal Industries Ltd image
Vadilal Industries Ltd
NA4,030.35119.64%0.621501,238
Annapurna Swadisht Ltd image
Annapurna Swadisht Ltd
NA552.5920.2%0.6421407
Madhusudan Masala Ltd image
Madhusudan Masala Ltd
NA206.635.05%0.7215230
Mrs Bectors Food Specialities Ltd image
Mrs Bectors Food Specialities Ltd
BUY8,536.7926.8%0.571431,873
See all

Nath Bio-Genes (India) Ltd Stock's Interest Amongst Investors

Search interest for Nath Bio-Genes (India) Ltd Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

Nath Bio-Genes (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
21.73
25.3
44.99
235.28
22.57
31.74
43.04
243.88
32.19
36.87
51.97
283.7
Other Income
0.2
0.06
0.26
0.12
0.06
2.54
1.36
0.13
0.08
0.48
4.4
3.83
Total Income
21.93
25.36
45.24
235.4
22.63
34.27
44.4
244.01
32.27
37.35
56.37
287.53
Expenses
16.97
19.68
41.05
198.25
17.59
26.09
39.11
207.34
27.38
28.84
51.55
245.42
Operating Profit
4.76
5.62
3.94
37.03
4.98
5.65
3.93
36.54
4.81
8.03
0.42
38.28
Operating Profit Margin %
21.91%
22.21%
8.76%
15.74%
22.06%
17.8%
9.13%
14.98%
14.94%
21.78%
0.81%
13.49%
Profit Before Interest, Tax and Depreciation
4.95
5.67
4.19
37.15
5.04
8.18
5.29
36.67
4.89
8.51
4.82
42.11
Interest
2.75
2.96
1.53
2.76
2.44
2.84
1.07
2.24
2.98
3.9
1.37
3.2
Depreciation
0.67
0.67
0.99
0.76
0.76
0.76
0.98
0.83
0.83
0.83
1.34
0.98
Profit Before Tax
1.53
2.04
1.67
33.63
1.84
4.58
3.24
33.6
1.08
3.78
2.11
37.93
Tax Paid
0.06
0.7
0.23
0.22
0.35
0.77
0.62
0.25
-0.03
1.14
0.63
0.66
Profit After Tax
1.47
1.35
1.44
33.4
1.5
3.82
2.62
33.35
1.11
2.65
1.48
37.28
Total Net profit including share of profit / Loss from associate company
1.47
1.35
1.44
33.4
1.5
3.82
2.62
33.35
1.11
2.65
1.48
37.28
EPS
0.77
0.71
0.77
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
Actual EPS
0.77
0.71
0.77
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
Adjusted EPS
0.77
0.71
0.77
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58
Diluted EPS
0.77
0.71
0.77
17.59
0.86
2.02
1.87
17.49
0.53
1.33
0.42
19.58

Nath Bio-Genes (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
278.36
301.36
332.62
364.91
Other Income
1.85
0.55
4.08
5.09
Total Income
280.22
301.92
336.7
369.99
Expenses
329.96
252.62
282.76
315.11
Operating Profit
-51.6
48.74
49.86
49.8
Operating Profit Margin %
-18.54%
16.17%
14.99%
13.65%
Profit Before Interest, Tax and Depreciation
-49.74
49.3
53.94
54.88
Interest
10.61
10.12
9.11
10.48
Depreciation
3.08
3.01
3.26
3.82
Profit Before Tax
-63.43
36.17
41.57
40.58
Tax Paid
3.95
1.15
1.95
1.98
Profit After Tax
-67.39
35.01
39.62
38.6
Total Net profit including share of profit / Loss from associate company
-67.39
35.01
39.62
38.6
EPS
-35.46
18.44
21.34
20.14
Actual EPS
-35.46
18.44
21.34
20.14
Adjusted EPS
-35.46
18.44
21.34
20.14
Diluted EPS
-35.46
18.44
21.34
20.14

Nath Bio-Genes (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.05
38.37
74.59
17.58
Cash Flow from Investing Activities
-19.86
-2.88
-27.41
-3.96
Cash Flow from Financing Activities
-22.23
-1.66
-7.78
-2.12
Net Cash Flow
-25.04
33.81
39.41
11.49

Nath Bio-Genes (India) Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
DII
4.62%
4.62%
4.62%
4.62%
4.37%
4.37%
4.37%
4.38%
4.37%
4.37%
3.94%
2.25%
FII
0%
0%
0%
0%
0.22%
0%
0.27%
0.22%
0.19%
0.19%
0.21%
0.42%
Public
49.77%
49.63%
49.65%
49.71%
49.81%
49.72%
49.76%
49.81%
49.85%
49.84%
50.25%
51.74%
Total Outstanding Shares
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
Total Shareholders
35,470
34,749
33,960
33,502
34,365
34,263
35,132
35,834
35,423
35,056
34,911
34,207

Mutual Funds that own Nath Bio-Genes (India) Ltd Stock

Check out the Mutual Funds with significant holdings in Nath Bio-Genes (India) Ltd.

Funds
Holdings
Shares Held
Aditya Birla Sun Life Value Fund Direct Plan Growth
Aditya Birla Sun Life Value Fund Direct Plan Growth
0.09%
307160

Nath Bio-Genes (India) Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Nath Bio-Genes (India) Ltd.

  • Nath Bio-Genes (India) Ltd Earnings Results

    Nath Bio-Genes (India) Ltd’s net profit jumped 11.78% since last year same period to ₹37.28Cr in the Q1 2025-2026. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated 2418.92% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Nath Bio-Genes (India) Ltd Dividends April,2025

    In the quarter ending March 2025, Nath Bio-Genes (India) Ltd has declared dividend of ₹2.00 per share on 29 Apr 2025 - translating a dividend yield of 2.38%.

    Read More about Dividends

Insights on Nath Bio-Genes (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 50.25% to 51.74% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 1.48 Cr → 37.28 Cr (in ₹), with an average increase of 96.0% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.21% to 0.41% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 32.27 Cr → 287.53 Cr (in ₹), with an average increase of 42.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Kaveri Seed Company Ltd has given 140.8% return, outperforming this stock by 148.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 45.60% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Avanti Feeds Ltd has given 4.0% return, outperforming this stock by 28.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, NATHBIOGEN stock has moved down by -17.5%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 3.89% to 2.25% in Jun 2025 quarter

About Nath Bio-Genes (India) Ltd

Nath BioGenes India Limited was established in 1993, as a private limited company, to produce, process and market hybrid and GM seeds. With 16 business centers spanning 131 territories across India, it has an extensive network of 2000 distributors, enabling it to cater to PAN India and far abroad markets in Asia, Africa and the Middle East. To improve the quality of its production, the company has incorporated modern infrastructure facilities, biotech and seed technology labs. Their range of field crop, vegetable crop and plant nutrient supplements have enabled it to gain various prestigious awards, such as the Vasantrao Naik Prathisthan Award, for its contribution towards enhancing agricultural productivity. It has also collaborated with major International and National Centres of Excellence, such as the NRCPB, CIMMYT, IRRI, and ICRISAT. The company has set rigorous field standards, quality control checks, and elaborate seed processing facilities, to ensure that only seeds of the highest quality reaches customers. Its 3-phase trial system with 40 testing locations, 8 centres, and all agroclimatic zones of India, has enabled it to rigorously test products and compare yields with competitor products. This comprehensive system has allowed Nath BioGenes India Limited to be a successful hybrid and GM seed provider in India and internationally.

Revenue: ₹283.70Cr as on June 2025 (Q1 FY26)
Net Profit: ₹37.28Cr as on June 2025 (Q1 FY26)
Listing date: 28 Jan, 2014
OrganisationNath Bio-Genes (India) Ltd
IndustryFMCG
E-voting on sharesClick here to vote

FAQs

What is Nath Bio-Genes (India) Ltd share price today?

Nath Bio-Genes (India) Ltd share price today stands at ₹168.38 as on at the close of the market. Nath Bio-Genes (India) Ltd share today touched a day high of ₹171.13 and a low of ₹166.

What is the 52 week high and 52 week low range for Nath Bio-Genes (India) Ltd share?

Nath Bio-Genes (India) Ltd touched a 52 week high of ₹238.69 and a 52 week low of ₹137.55. Nath Bio-Genes (India) Ltd share price today i.e. is closed at ₹168.38, which is -29.46% down from its 52 week high and 22.41% up from its 52 week low.

What is Nath Bio-Genes (India) Ltd's market capitalisation today?

Nath Bio-Genes (India) Ltd market capitalisation is ₹318.83 Cr as on .

How to buy Nath Bio-Genes (India) Ltd shares?

To buy Nath Bio-Genes (India) Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NATHBIOGEN or Nath Bio-Genes (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Nath Bio-Genes (India) Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Nath Bio-Genes (India) Ltd trading volume today?

Nath Bio-Genes (India) Ltd trading volume is 12.85K as on . This means that 12.85K shares of Nath Bio-Genes (India) Ltd were bought and sold on the stock market during today's trading session.